Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Quark Pharmaceuticals announces option agreement with Novartis for QPI-1002 siRNA drug

Silence Therapeutics plc, a leading international RNAi therapeutics company, is pleased to note that its partner, Quark Pharmaceuticals, Inc., has announced the grant of an option to Novartis to obtain an exclusive worldwide license to develop and commercialise QPI-1002, a p53 temporary inhibitor siRNA drug which incorporates Silence's AtuRNAi technology.

20 Aug 2010

MUH performs first intracranial radiosurgery with Leksell Gamma Knife Perfexion system

Macquarie University Hospital (MUH) performed Australia's first Gamma Knife surgery with its new Leksell Gamma Knife Perfexion system, making it the country's first and only center capable of providing dedicated intracranial radiosurgery.

20 Aug 2010

Elephant Capital and ClinTec International announce partnership deal

ClinTec International, a global Clinical Research Organisation ("CRO") announces financial and strategic partnership with Elephant Capital plc., a London AIM market listed private equity firm. With an investment of £8 Million GBP, Elephant has acquired a significant minority stake in ClinTec.

19 Aug 2010

MD Anderson Cancer Center receives $20 million to advance research on targeted therapies

Dallas businessman and philanthropist H. Ross Perot has donated $20 million to The University of Texas MD Anderson Cancer Center for research to advance and design novel targeted therapies.

19 Aug 2010

Siemens Healthcare to distribute Calypso GPS System in Europe

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced that it has entered into a non-exclusive product distribution agreement with Siemens Healthcare for the sale of its Calypso® System in Europe. Under terms of the agreement, Siemens retains non-exclusive rights to sell Calypso's real-time tracking technology to existing and prospective Siemens linear accelerator customers throughout Europe for a period of three years.

19 Aug 2010

TOPEX announces sale of skin cancer business operations to SENSUS Healthcare

TOPEX, Inc. announces the sale of its skin cancer business operations to SENSUS Healthcare, LLC for its low energy SRT 100 superficial radiotherapy treatment system. Since TOPEX received FDA approval during 2007, many systems have been operating worldwide at hospital radiation oncology centers, dermatology and veterinary oncology practices for the treatment of skin cancer.

19 Aug 2010

FDA accepts to review Bristol-Myers Squibb's ipilimumab for melanoma

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA.

19 Aug 2010

WFNS launches 'World Neurosurgery' journal

The World Federation of Neurosurgical Societies (WFNS) representing more than 30,000 neurosurgeons, 114 individual societies and 100 nations has launched World Neurosurgery, the specialty's first publication acting as a global forum for not only high level peer reviewed, clinical and laboratory science, but also the social, political, economic, cultural and educational issues that affect research and care delivery regionally and from a global perspective.

18 Aug 2010

FDA grants BSD Medical marketing clearance for MicroThermX Microwave Ablation System

BSD Medical Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a 510(k) clearance to market its MicroThermX Microwave Ablation System (MTX-180) for ablation of soft tissue. Clearance from the FDA of BSD's 510(k) Premarket Notification submission authorizes the commercial sale of the MTX-180 in the United States. The MTX-180 was designed to provide a higher power, optimized system targeted to the growing therapeutic interventional and surgical oncology market.

18 Aug 2010

IRIS International announces approval of share repurchase program

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that, effective immediately, its Board of Directors has approved a repurchase program for up to $10 million in shares of the Company's common stock over a twelve month period.

18 Aug 2010

Xcelligence System provides real-time detection of neuronal cell death

Time course analyses of neuronal cell death and its underlying mechanisms require laborious experiments and multiple endpoint assays, often involving labelling with irritating compounds and cell disruption. A recent study used the xCELLigence System of Roche to investigate the response of the neuronal-like cell line HT-22 and cultured primary rat cortical neurons to different cell death stimuli and neuroprotectants.

18 Aug 2010

Robotic prostatectomy has low complication rates: CINJ study

According to a new study by The Cancer Institute of New Jersey (CINJ), new evidence proves the safety of a robotic prostatectomy with the lowest complication rates in prostate cancer treatment. This comes as no surprise to Dr. David Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New York, who has performed over 3,000 successful robotic prostate surgeries in the fight against prostate cancer.

18 Aug 2010

USPTO grants Neogenix Oncology patent for DNAs encoding novel molecular aspects of NPC-1 antibody

Neogenix Oncology, Inc. announced today that the U.S. Patent and Trademark Office (USPTO) has issued Patent No. 7,763,720, with claims related to DNAs encoding the novel molecular aspects of the Company's NPC-1 antibody.

18 Aug 2010

Varian to showcase new Gated RapidArc technology at 2010 CHINA-HOSPEQ exhibition

Varian Medical Systems, Inc. will showcase the company's new Gated RapidArc technology on its Trilogy® machine with advanced motion management capabilities at the 2010 CHINA-HOSPEQ exhibition being held in Beijing August 19-21 by China's Ministry of Health. Varian, the world's leading manufacturer of medical technology for treating cancer and a premier supplier of X-ray imaging technology, will also exhibit its software for planning and for managing radiation therapy treatments.

18 Aug 2010

Adult stem cells associated with poor prognosis of cancer: Research

Adult stem cells that are vital for airway repair in the lung but that persist in areas where pre-cancerous lesions are found are associated with a poor prognosis in patients who develop cancer, even those with early stage disease, researchers at UCLA's Jonsson Comprehensive Cancer Center have found.These adult stem cells are found in repairing areas after injury and also are found in pre-cancerous areas, suggesting that these cells may mutate and become cancer causing stem cells, making them a potential cell-of-origin for lung cancer and a possible target for prevention strategies and new targeted therapies.

18 Aug 2010

ImmunoCellular Therapeutics raises $6.5 million in second quarter 2010

ImmunoCellular Therapeutics today announced second quarter results for the period ended June 30, 2010. The Company utilized $1.13 million of cash in its operations during the quarter. The increase in net burn is reflective of increased personnel costs as well as increase in Research and Development costs associated with the planned phase II clinical trial for ICT-107.

18 Aug 2010

Cancer Institute of New Jersey expands 'Quality and Outcomes in Cancer Care Research Program'

Looking to gain further understanding about the impact of cancer on patients and families, The Cancer Institute of New Jersey (CINJ) is expanding its Quality and Outcomes in Cancer Care (QOCC) Research Program by welcoming nationally-recognized population science researcher Sharon Manne, PhD. Dr. Manne, who is the recipient of major grant awards from the National Institutes of Health (NIH) for her work in behavioral science, was most recently at the Fox Chase Cancer Center in Philadelphia. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

17 Aug 2010

European Cancer Cluster Meeting 2010 to be held September 15-17 in Oslo, Norway

Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.

17 Aug 2010

PRA International to host audio conference on CV drug development strategy

PRA International, a leading Clinical Research Organization, will host an audio conference on strategies for successful cardiovascular (CV) drug development on 24 August 2010 at 11:30 am (EDT). Dr. Michael Kirchengast, Vice President and Head of PRA's Scientific Affairs unit, will be the presenter.

17 Aug 2010

Nanoparticle-based gene silencing system inhibits angiogenesis process in tumor growth

A protein associated with cancer progression when abundant inside of tumors also unexpectedly regulates the creation of new blood vessels that feed the tumor outside, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the August edition of Cancer Cell.

17 Aug 2010

Oncology News and Research

Further Reading

Quark Pharmaceuticals announces option agreement with Novartis for QPI-1002 siRNA drug

MUH performs first intracranial radiosurgery with Leksell Gamma Knife Perfexion system

Elephant Capital and ClinTec International announce partnership deal

MD Anderson Cancer Center receives $20 million to advance research on targeted therapies

Siemens Healthcare to distribute Calypso GPS System in Europe

TOPEX announces sale of skin cancer business operations to SENSUS Healthcare

FDA accepts to review Bristol-Myers Squibb's ipilimumab for melanoma

WFNS launches 'World Neurosurgery' journal

FDA grants BSD Medical marketing clearance for MicroThermX Microwave Ablation System

IRIS International announces approval of share repurchase program

Xcelligence System provides real-time detection of neuronal cell death

Robotic prostatectomy has low complication rates: CINJ study

USPTO grants Neogenix Oncology patent for DNAs encoding novel molecular aspects of NPC-1 antibody

Varian to showcase new Gated RapidArc technology at 2010 CHINA-HOSPEQ exhibition

Adult stem cells associated with poor prognosis of cancer: Research

ImmunoCellular Therapeutics raises $6.5 million in second quarter 2010

Cancer Institute of New Jersey expands 'Quality and Outcomes in Cancer Care Research Program'

European Cancer Cluster Meeting 2010 to be held September 15-17 in Oslo, Norway

PRA International to host audio conference on CV drug development strategy

Nanoparticle-based gene silencing system inhibits angiogenesis process in tumor growth

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News